Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.
Barkhof F, Held U, Simon JH, Daumer M, Fazekas F, Filippi M, Frank JA, Kappos L, Li D, Menzler S, Miller DH, Petkau J, Wolinsky J; Sylvia Lawry Centre for MS Research.
Barkhof F, et al.
Neurology. 2005 Nov 8;65(9):1447-54. doi: 10.1212/01.wnl.0000183149.87975.32.
Neurology. 2005.
PMID: 16275834